BlogUncategorized

GeneLancet presented at the 27th ASGCT meeting and...

DOYLESTOWN, PA, June 11th, 2024-GeneLancet presented at the 27th ASGCT meeting a...

BlogUncategorized

GeneLancet presented at 2023 26th ASGCT annual meeting.

GeneLancet presented at 2023 26th ASGCT annual meeting. We reported the progress...

BlogUncategorized

GeneLancet Biosciences Inc. announces its receipt of additional...

DOYLESTWON, PA, January 31, 2024 – GeneLancet Biosciences Inc. (“Gen...

BlogUncategorized

GeneLancet Biosciences Inc. has appointed Leonid Beigelman, Ph.D.,...

DOYLESTWON, PA, January 31, 2024 – GeneLancet Biosciences Inc. has appoint...

BlogUncategorized

GeneLancet Biosciences Announces Phase 1 SBIR Award from...

Doylestown, April 6, 2023 – GeneLancet Biosciences, a pre-clinical stage b...

Load More